Platelia Aspergillus assay for diagnosis of disseminated histoplasmosis

S Ranque1, R Pelletier, A Michel-Nguyen

  • 1Laboratoire de Parasitologie-Mycologie, AP-HM Timone, Marseille Cedex 5, France. stephane.ranque@ap-hm.fr

Insights

The Platelia Aspergillus assay can aid in diagnosing disseminated histoplasmosis in patients outside the USA. This test shows cross-reactivity, offering a valuable alternative when Histoplasma capsulatum antigen tests are unavailable.

Area of Science:

  • Medical Mycology
  • Clinical Diagnostics

Background:

  • Disseminated histoplasmosis diagnosis is challenging, especially outside the USA.
  • Current diagnostic methods for histoplasmosis have limitations.

Purpose of the Study:

  • To evaluate the utility of the Platelia Aspergillus assay for diagnosing disseminated histoplasmosis.
  • To assess the cross-reactivity of the Platelia Aspergillus assay in histoplasmosis patients.

Main Methods:

  • The Platelia Aspergillus assay was performed on patients with disseminated histoplasmosis.
  • Results were compared to other diagnostic methods.

Main Results:

  • The Platelia Aspergillus assay yielded positive results in 8 out of 11 (73%) patients with disseminated histoplasmosis.
  • This assay demonstrated valuable cross-reactivity for diagnosing histoplasmosis.

Conclusions:

  • The Platelia Aspergillus assay is a potentially useful diagnostic tool for disseminated histoplasmosis, particularly in regions where specific Histoplasma antigen tests are inaccessible.
  • Cross-reactivity of the assay provides a viable alternative diagnostic approach.

Related Concept Videos